Mereo BioPharma
Path cleared for partnering of acumapimod (BCT-197)Mereo BioPharma
Executing a well articulated strategyMereo BioPharma
Merger with NASDAQ-listed OncoMedMereo BioPharma
Phase II starts with backing from patient support groupMereo BioPharma
Raring to go in rare diseases